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1. Introduction 
Ceruloplasmin, a copper containing blue colored 
protein (molecular weight 160,000), has moderate 
amounts of oxidase activity towards a variety of 
polyamines and polyphenols [l] . It has been known 
for quite some time that estrogen in the form of 
ethinyl estradiol [2] or stilbestrol [3] causes a mark- 
ed increase in serum copper levels (which reflects 
serum ceruloplasmin levels). More recently some re- 
ports have appeared showing increased serum cerulo- 
plasmin [4] and copper [5] levels in women taking 
oral contraceptives. The authors attributed this ef- 
fect to the estrogen component present. However, 
in our laboratory altogether different results were 
obtained in rabbits; while progesterone had profound 
influence in increasing serum ceruloplasmin activity, 
similar to stilbestrol, estradiol, after causing a slight 
increase in the first week, caused a small but steady 
decrease [6]. There is also evidence that cortisol 
[7] causes a decrease in serum copper levels in man. 
Administration of cortisol, it is established, suppres- 
ses the secretion of endogenous ACTH thereby adre- 
nal steroidogenesis i  also suppressed. This can lead 
to a lowering in the serum of some of the steroids at 
the beginning steps of adrenal steroidogenesis, like 
progesterone 0; 17-hydroxypregnenolone [8] and, 
presumably, the latter could be the reason for the 
lowering of serum copper. It could then be hypo- 
thesized that administration of ACTH could result 
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in elevation of serum ceruloplasmin, and that ACTH 
and cortisol could have opposing effects in this res- 
pect. To test this hypothesis the following experi- 
ment was done. 
2. Methods 
Six healthy male and 2 healthy non-pregnant 
female rabbits weighing about l- 1.5 kg were used. 
In 3 males and in the 2 females 7 I.U. of ACTH 
(Acton) per rabbit were administered subcutaneously. 
Blood samples were drawn before, and one week af- 
ter, administration of the hormone. In the other 3 
males 25 mg of hydrocortisone acetate (Wycort) per 
rabbit were given subcutaneously in four injectibns 
(1 st, 3rd, 6th and 10th day), and blood samples were 
also drawn before, 1 week, and 2 weeks after the 
first injection. Serum ceruloplasmin activity was 
estimated on the following day always simultaneous- 
ly with two serum samples of control rabbits using 
p-phenylenediamine (PPD) oxidation, adopting the 
method of Ravin [9. lo]. 
Acetate buffer, 8 ml (PH 5.5), 0.1 ml serum and 
1 .O ml 0.5% substrate (PPD) were incubated at 37” 
for 1 hr. The oxidation reaction was arrested by 1 ml 
0.5% sodium azide, and after cooling to lo- 15” for 
30 min, the colour intensity read in a photoelectric 
calorimeter; an experimental control (other than the 
serum samples of two control rabbits) for each serum 
sample was also set up simultaneously by adding sod- 
ium azide before adding PPD. The values are ex- 
pressed as the optical density, without converting to 
mg ceruloplasmin per 100 ml by using a conversion 
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Fig. 1. Effects of ACTH and of cortisol on serum ceruloplasmin in rabbits. 3 male and 2 female rabbits were each given a single 
subcutaneous injection of 7 LU. of ACTH. Serum ceruloplasmin activity was estimated before (initial) and one week after the 
injection. 3 male rabbits were each given subcutaneously 25 mg hydrocortisone acetate on lst, 3rd, 6th and 10th day of the ex- 
periment. Ceruloplasmin was estimated before, 1 week, and 2 weeks after the first injection. All individual values are shownThe 
effect of progesterone (o - - o) is the average response of 8 rabbits on giving 20 mg of progesterone in divided doses over 1 week. 
The latter is quoted from Indian J. Exptl. Biol. [6], by the kind permission of the editor. 
factor [9] ; this is equally dependable [9, lo] and 
moreover was felt safer since no useful standard was 
available. The substrate solution was always prepared 
fresh to get the optical density reading of the con- 
trol between 0.050 and 0.090. 
3. Results and discussion 
The ceruloplasmin values of each rabbit in res- 
ponse to ACTH and to cortisol are shown in fg. 1; 
for comparison the corresponding mean response of 
8 rabbits to progesterone also is shown. It appears 
convincing that ACTH has profound influence in in- 
creasing serum ceruloplasmin, since in all 5 rabbits 
a marked increase was noted in 1 week in response 
to a single injection of 7 I.U. of ACTH. The decrease 
in ceruloplasmin levels in response to hydrocortisone 
is probably due to suppression of ACTH production. 
The long term influence of ACTH, however, was 
not tested. There is evidence [ 1 l] that in leukemic 
patients treatment with ACTH for l-l 45 months 
causes a decrease in serum copper levels. The sustain- 
ed elevation of cortisol and of other terminal steroids 
in the adrenal steroidogenesis as a result of the con- 
tinual stimulation by ACTH might have caused this. 
It could also be possible that the ratio between ster- 
oids in the beginning and final steps of steroidogen- 
esis influences the ceruloplasmin levels. However, 
the long term response to ACTH need not be the 
same in normal humans or rabbits as in leukemic 
patients. 
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The results of this and of the previous communi- 
cation [6] suggest hat there could be steroids other 
than progesterone that have this influence, and that 
some of them may be much more potent than pro- 
gesterone, since ACTH is apparantly more potent 
than the former (see fig. 1). It appears, therefore, 
worthwhile to screen all steroids to find out the 
relative potency of each with regard to this property 
and to delineate the minimal structural requirement 
for the same. For instance, a side chain at C-17 may 
be essential since ethinyl estradiol [2], having the 
ethinyl side chain at C-17, does cause an increase 
while estradiol having no side chain at C-l 7 does not 
have this influence [6]. However, cortisol having a 
side chain at C-17 has no positive influence; the 
other aspects of its structure, like the configuration 
at C-l 1, may be responsible for this. It would also 
be worthwhile to correlate this property of the ste- 
roids with their biological functions. A further step 
could be that some of the most potent steroids in 
this respect could be tried in the treatment of Wil- 
son’s disease; they may be able to mobilize the tissue 
copper for the synthesis of serum ceruloplasmin. 
Although at this stage it appears far-fetched, a spec- 
ulation may be made that Wilson’s disease might be 
the result of a genetic defect in the synthesis of a 
special steroid, powerful like aldosterone for the 
synthesis of serum ceruloplasmin; a hypothetical 
equilibrium between serum copper bound to cerulo- 
plasmin and tissue copper is shifted to the right by 
this. 
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